Please login to the form below

Not currently logged in
Email:
Password:

The Competition and Markets Authority

This page shows the latest The Competition and Markets Authority news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca clears latest hurdle for Alexion acquisition after EU clearance

AstraZeneca clears latest hurdle for Alexion acquisition after EU clearance

The EU clearance comes after similar competition clearances in the US, Japan and other global regulatory agencies, AZ said in a statement. ... In May, the UK’s Competition and Markets Authority (CMA) announced that it was reviewing AZ’s proposed

Latest news

  • UK’s Competition and Markets Authority to review AZ/Alexion merger UK’s Competition and Markets Authority to review AZ/Alexion merger

    The UK’s Competition and Markets Authority (CMA) is set to review AstraZeneca’s (AZ) planned takeover of rare diseases specialist Alexion. ... Competition clearances have also been completed in Canada, Brazil, Russia and other countries.

  • Roche to close $4.3bn Spark deal after FTC clearance Roche to close $4.3bn Spark deal after FTC clearance

    The US antitrust approval swiftly follows the clearance from the UK’s Competition and Markets Authority (CMA), which announced early yesterday that its investigation into the merger was complete. ... However, the antitrust authority finally concluded

  • UK’s CMA clears Roche’s $4.3bn takeover of Spark UK’s CMA clears Roche’s $4.3bn takeover of Spark

    the UK's Competition and Markets Authority (CMA) finally approved the deal. ... The CMA therefore found that the deal between Roche and Spark would not negatively affect competition because UK health services and patients will still have an adequate

  • Pfizer, Flynn face reinstatement of £90m CMA fine Pfizer, Flynn face reinstatement of £90m CMA fine

    Facing penalty for dramatic price hikes of an epilepsy drug. The UK’s competition regulator is pushing to reinstate a £90m fine for Pfizer and Flynn Pharma – quashed last year – over ... The case dates back to 2015, when the Competition and

  • Roche moving closer to approval of Spark takeover; report Roche moving closer to approval of Spark takeover; report

    Competition and Markets Authority (CMA) have taken their time to probe antitrust issued raised by the deal. ... The Capitol Forum report suggests that review staff are happy to accept the deal, but that senior officials at the FTC's Bureau of

More from news
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Biosimilars and beyond: innovating for improved patient outcomes
How Europe’s biosimilar landscape has rapidly evolved over the last two decades, bringing biological medicines to more patients than ever before...
World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
Strategic behaviour
Strong strategising depends on your colleagues’ behaviour...